Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,904
Closed -$200K 124
2025
Q4
$200K Sell
1,904
-1,256
-40% -$118K 0.53% 75
2025
Q3
$265K Sell
3,160
-638
-17% -$52.5K 0.37% 103
2025
Q2
$301K Buy
+3,798
New +$302K 0.49% 52
2022
Q3
$959K Hold
11,133
0.52% 58
2022
Q2
$1.01M Buy
11,133
+675
+6% +$59.8K 0.46% 73
2022
Q1
$858K Buy
10,458
+3,000
+40% +$237K 0.26% 98
2021
Q4
$572K Buy
7,458
+2,486
+50% +$198K 0.21% 115
2021
Q3
$373K Hold
4,972
0.11% 164
2021
Q2
$387K Sell
4,972
-239
-5% -$17.8K 0.13% 149
2021
Q1
$383K Hold
5,211
0.16% 130
2020
Q4
$407K Buy
+5,211
New +$399K 0.23% 74

Other funds holding MRK

Olympiad Research's MRK Position: Q1 2026 in Review

Olympiad Research sold out of Merck (MRK) in Q1 2026, closing a stake of 1,904 shares — an estimated $200K sold.

Olympiad Research first reported a position in MRK in Q4 2020 and held it in 11 quarters. The position peaked at $1.01M in Q2 2022. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Olympiad Research reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Olympiad Research sold 1,904 Merck shares in Q1 2026, an estimated $200K.
  • Olympiad Research first reported a position in Merck in Q4 2020 and held it in 11 quarters.
  • Olympiad Research's Merck position peaked at $1.01M in Q2 2022.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Olympiad Research's 13F filing for Q1 2026, filed 13 May 2026.